We found that B16F10 and KPC models recapitulate the main signs of cancer cachexia observed in humans in terms of weight changes, splenomegaly, increase in plasmatic MCP1 and levels of carbonylated proteins, and reduction in tryptophan in plasma and skeletal muscle alterations. This evidence concerns the gene CCL2 and cancer.